Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002540 · ClinicalTrials.gov registry record · NA
Screening for Prostate Cancer in Older Patients (PLCO Screening Trial)
A NA study of Prostate Carcinoma, sponsored by National Cancer Institute (NCI).
- Active
- Registry status
- NA
- Development phase
- 76,685
- Enrollment target
- 1
- Study location
NCT00002540 is a NA study of Prostate Carcinoma that is active but no longer recruiting, run by National Cancer Institute (NCI). The registered enrollment target is 76,685 participants, above the 202-participant average among 59 other Prostate Carcinoma trials with a reported enrollment target (37863% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00002540, a NA study of Prostate Carcinoma, is active but no longer recruiting, sponsored by National Cancer Institute (NCI).
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 76,685 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial studies whether screening methods used to diagnose cancer of the prostate, lung, colon, rectum, or ovaries can reduce deaths from these cancers. Screening tests may help doctors find cancer cells early and plan better treatment for prostate cancer.
Conditions Studied
Interventions
- OTHER Laboratory Biomarker Analysis
- OTHER Screening Questionnaire Administration
- PROCEDURE Medical Examination Assessment
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76,685 participants |
| Start Date | 1993-11-16 |
| Est. Completion | 2026-03-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002540
The ClinicalTrials.gov registry entry for NCT00002540 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 76,685 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 202-participant average among 59 other Prostate Carcinoma trials with a reported enrollment target (37863% higher). The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Prostate Carcinoma appearing as the primary indexed condition, and to 3 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT00002540 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT00002540 about?
NCT00002540 is a clinical study titled "Screening for Prostate Cancer in Older Patients (PLCO Screening Trial)". This clinical trial studies whether screening methods used to diagnose cancer of the prostate, lung, colon, rectum, or ovaries can reduce deaths from these cancers. Screening tests may help doctors find cancer cells early and plan better treatment for prostate cancer.
What is the current status of trial NCT00002540?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 76,685 participants. The study started on 1993-11-16. Estimated completion is 2026-03-25.
What conditions does trial NCT00002540 study?
This clinical trial studies the following conditions: Prostate Carcinoma.
What interventions are being tested in trial NCT00002540?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Screening Questionnaire Administration (OTHER), Medical Examination Assessment (PROCEDURE).
Who is sponsoring clinical trial NCT00002540?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00002540 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVE
RECRUITING · NA
-
Community-Based Health Coach for Access to Germline Genetic Testing Among African American Men With Prostate Cancer
RECRUITING · NA
-
Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers
RECRUITING · NA
-
[18F]-rhPSMA PET-CT Imaging Performance in Patients With Prostate Cancer
RECRUITING · NA
-
Brain and Pelvic Floor Muscle Activity of Patients Who Had or Are Undergoing Robot-Assisted Radical Prostatectomy
RECRUITING · NA
-
Reduction of Gastrointestinal Toxicity in Prostate Cancer by Proton Spot Placement
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.